SYNE1 mutation may enhance the response to immune checkpoint blockade therapy in clear cell renal cell carcinoma patients
2021 ◽
2020 ◽
Vol 135
◽
pp. 203-210
◽
Keyword(s):
2018 ◽
Keyword(s):
2019 ◽
Vol 380
(26)
◽
pp. 2581-2582
◽
Keyword(s):
2019 ◽
Keyword(s):